Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention

Journal of Invasive Cardiology

Volumn 20, Issue 3, 2008, Pages 108-112

  Andron, Mohammed ^a   Stables, Rodney H ^a   Egred, Mohaned ^a   Alahmar, Albert E ^a   Shaw, Matthew A ^a   Roberts, Elved ^a   Albouaini, Khaled ^a   Grayson, Anthony D ^a   Perry, Raphael A ^a   Palmer, Nicholas D ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOGENIC SHOCK; CORONARY STENT; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE NECROSIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SAMPLE SIZE; ST SEGMENT ELEVATION; TERTIARY HEALTH CARE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY DISEASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STENTS;

EID: 40449088895     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fractions after percutaneous coronary interventions. Circulation 1996;94:1528-1536.
2. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-251.
3. Tardiff BE, Califf RM, Tcheng JE, et al, for the IMPACT-II Investigators. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 1999;33:88-96.
4. Simoons ML, Van den Brand M, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J 1999;20:1112-1119.
5. Harrington RA. Cardiac enzyme elevations after percutaneous coronary intervention: Myonecrosis, the coronary microcirculation, and mortality. J Am Coll Cardiol 2000;35:1142-1144.
6. Holmes DR Jr, Berger PB. Troponisms, necrosettes, enzyme leaks, creatine phosphokinase bumps, and infarclets: What's behind this new lexicon and what does it add? Circulation 2001;104:627-629.
7. Cavallini C, Savonitto S, Violini R, et al. Thrombo impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study. Eur Heart J 2005;26:1494-1498.
8. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis. Are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002;105:554-556.
9. Ioannidis JPA, Karvouni E, Kastrisis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1406-1411.
10. Colombo A, Stankovic G. Nothing is lower than 0, and 3 is closer to 0 than to 5 - Medicine is not arithmetic. Eur Heart J 2002;23:840-842.
11. Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course. J Am Coll Cardiol 1999;34:663-671.
12. Ellis SG, Chew D, Chan A, et al. Death following creatine kinase-MB elevation after coronary intervention: Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 2002;106:1205-1210.
13. Stone GW, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation 2001;104:642-647.
14. Cutlip DE, Kuntz RE. Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. Circulation 2005;112:916-922.
15. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35:1134-1141.
16. Kugelmass AD, Cohen CJ, Moscucci M, et al. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 1994;74:748-754.
17. Cutlip DE, Chauhan M, Lasorda D, et al. Influence of post-procedural myocardial infarction on late clinical outcome in the Stent Anti-Thrombotic Regimen Study (STARS). Circulation 1997;96(Suppl 1):131.
18. Cutlip DE, Chauhan M, Senerchia C, et al. Influence of myocardial infarction following otherwise successful coronary intervention on late mortality. Circulation 1997;96(Suppl 1):I30.
19. Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2005;111:2099-2106.
20. Briguori C, Colombo A, Airoldi F, et al. Statin administration before percutaneous coronary intervention: Impact on periprocedural myocardial infarction. Eur Heart J 2004;25:1822-1828.
21. Mulukutla SR, Marroquin OC, Smith C, et al. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. Am J Cardiol 2004;94:1363-1366.
22. Pasceri V, Patti G, Nusca A, et al, on behalf of the ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004;110:674-678.
23. Patti G, Pasceri V, Colonna G, et al. Atorvastatin for Reduction of Myocardial Damage during Angioplasty - Acute Coronary Syndromes (ARMYDA-ACS). J Am Coll Cardiol 2007;49:1272-1278.
24. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-580.
25. Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006;114:662-669.
26. Iakovou I, Mintz GS, Dangas G, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2003;42:1900-1905.
27. Brener SJ, Ellis SG, Schneider J, Topol EJ. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 2002;23:869-876.
28. Jeremias A, Baim DS, Ho KK, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol 2004;44:1210-1214.
29. Jacobey JA, Taylor WJ, Smith GT, et al. A new therapeutic approach to acute coronary occlusion. Am J Cardiol 1962;9:60-73.
30. Kaplinsky E, Ogawa S, Balke W, Dreifus L. Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation 1979;60:397-403.
31. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-2783.
32. Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027-1032.
33. Bhatt DL, Topol EJ, Cutlip DE, Kuntz RE. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Circulation 2005;112:906-915.